Actemra 50242-0138
Generic: Tocilizumab
Product NDC
50242-0138- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 21, 2013
- Listing Expires
- December 31, 2026
- Application
- BLA125472
Need to source Actemra? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tocilizumab | 162 mg/.9mL |
Drug Class
Interleukin-6 Receptor Antagonist [EPC]Interleukin 6 Receptor Antagonists [MoA]Interleukin-6 Receptor Antagonist [EPC]
Packaging Options(2)
1 SYRINGE, GLASS in 1 BOX (50242-138-01) / .9 mL in 1 SYRINGE, GLASS
1 SYRINGE, GLASS in 1 BOX (50242-138-86) / .9 mL in 1 SYRINGE, GLASS